Skip to main content

Rolling Action Plan – our chemical evaluations list

The Rolling Action Plan lists our current and recently completed chemical evaluations. The Rolling Action Plan forms part of our approach to protecting human health and the environment.

Decorative image

 

What is the Rolling Action Plan?

The Rolling Action Plan is our work plan for prioritising chemicals for evaluation, which are selected based on the outcomes of our Evaluation Selection Analysis (ESA) process.

The plan lists our proposed, ongoing and recently completed chemical evaluations. It doesn't include evaluations initiated for chemicals under a current assessment certificate. 

Our Evaluations Roadmap describes our strategic approach to protect human health and the environment by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritising chemicals on the Inventory, our evaluations are more risk-proportionate, timely and targeted.

For each entry, the Rolling Action Plan includes the: 

  • subject of the evaluation – typically the chemical name or chemical group name
  • reason for the evaluation
  • an estimated evaluation end date
  • focus of the evaluation – chemical identity, and human health or the environment (or both)
  • amendments to the list of our initiated evaluations.

The publication of the subject, reason and time period within which the evaluation will be conducted satisfies the requirements of the Industrial Chemicals Act 2019  for initiating an evaluation. Listing the evaluation on the RAP means that it has commenced. An estimated time period for conducting the evaluation is provided in the table below.

During an Evaluation Selection Analysis (ESA) process we will identify chemicals that may pose a risk to human health and/or the environment. We will also identify chemicals that are unlikely to require further regulation to manage risks based on their human health and environmental hazards and exposures. This will allow us to publish Evaluation Statements for these chemicals and provide the rationale for not undertaking more detailed evaluations.

    When do we update the Rolling Action Plan? 

    Generally, we will update the Rolling Action Plan after publishing our evaluations. We publish a notice on our website when we update it. 

    We will add details of newly initiated evaluations. Other changes to the rolling action plan may include amendments to the: 

    • evaluation subject
    • estimated evaluation end date
    • reason for the evaluation

    We may need to update the Rolling Action Plan at other times. If we do, we’ll consult with interested parties and publish a notice on our website. These updates can happen for many reasons, including:

    • an adverse event that warrants a chemical evaluation
    • a stakeholder request to evaluate a chemical has been prioritised through ESA process
    • a post-assessment obligation leads to an evaluation
    • we are informed that new information will become available for the chemical that warrants a chemical evaluation

    The identified chemicals covered by the subject of the evaluation may change as the evaluation progresses due to new information becoming available.

    Completed evaluations remain on the Rolling Action Plan until the next set of evaluations are published. 

    Note: Please contact us if you have any information about any chemical listed on the Rolling Action Plan.

    Rolling Action Plan

    Evaluations under consultation, in progress and recently completed

      We publish and maintain the following information as part of the Rolling Action Plan. 

      1. Lists of evaluations that are in progress, currently open for public consultation or recently completed. Each evaluation could be for a single chemical or a group of chemicals.
      2. Downloadable spreadsheet of chemicals that are covered by an evaluation that is in progress, currently open for public consultation, or recently completed. These chemicals can change during the course of the evaluation if new information becomes available.

      Download

      Evaluations under public consultation

      The following evaluations are open for consultation until 27 November 2023 - go to our consultation page, where you'll also be able to download drafts.
      EvA ID Subject of evaluation Reason for evaluation Evaluation estimated end date Focus Amendments to RAP
      EVA00121 Acetoin, cinnamaldehyde, diethylene glycol and ethylene glycol with end use in non-nicotine e-cigarettes (vaping products) Evaluation Selection Analysis indicated a potential human health risk. 31/12/2023 Health -
      EVA00123 1-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium salt Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00124 1-Propene, 3-chloro-2-methyl- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00125 2-Butanone, oxime (MEKO) New information is available about human health risks. 30/06/2024 Health -
      EVA00127 2-Methoxyethyl methacrylate and 2-ethoxyethyl methacrylate Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00128 2-Propenamide, N,N'-methylenebis- (N,N'-methylenebisacrylamide) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00129 2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester (ethylhexyl methacrylate) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00132 Alkoxysilanes substituted with 2-ethoxyethanol Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00133 Benzenamine, N-phenyl- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00134 Benzene, 1-methoxy-4-nitro- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00137 Chlorendic acid and chlorendic anhydride Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health The subject of the evaluation has been changed to include chlorendic anhydride. Chlorendic anhydride hydrolyses to chlorendic acid in contact with aqueous media. The evaluation will consider data on both chlorendic acid and chlorendic anhydride.
      EVA00138 Chemicals not considered for in depth evaluation – Not commercially active in Australia Evaluation is needed to provide information on human health and environmental risks. 30/06/2024 Health and Environment -
      EVA00139 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 30/06/2024 Environment -
      EVA00140 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 30/06/2024 Health -
      EVA00142 Cyclohexanamine, 4,4'-methylenebis- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00144 Fluorescent Brightener 71 and related chemicals Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2024 Environment -
      EVA00145 Glycidyl neodecanoate and glycidyl tert-decanoate Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00148 Morpholine, 4-(1-oxo-2-propenyl)- (acryloyl morpholine) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00149 Hydroxymethylated imidazolidinones Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2024 Environment -
      EVA00152 Tetrahydrofurfuryl acrylate and tetrahydrofurfuryl methacrylate Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -

      Evaluations in progress

      EvA ID Subject of evaluation Reason for evaluation Evaluation estimated end date Focus Amendments to RAP
      EVA00105 Water-soluble zinc salts Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2024 Environment The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment.
      EVA00122 1H-Benzotriazole and its mono-substituted derivatives Evaluation Selection Analysis indicated a potential human health risk. 31/12/2024 Health -
      EVA00126 2-Ethylhexyl phosphates Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2024 Environment -
      EVA00130 Acrylates and methacrylates based on bisphenol A (BPA) Evaluation Selection Analysis indicated a potential human health risk. 31/12/2024 Health -
      EVA00131 Alkoxysilane ethylenediamine and polyamine derivatives Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00135 Benzenesulfonic acid, dodecyl-, compound with 4,4-dimethyloxazolidine (1:1) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00136 Benzoic acid, 2-hydroxy-, methyl ester (methyl salicylate) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00141 Cyanoacrylates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2024 Health -
      EVA00143 Environmental fate and effects of zinc ions Evaluation is needed to provide information on environmental risks. 30/06/2024 Environment -
      EVA00146 Medium and long chain alkyl sulfates Evaluation Selection Analysis indicated a potential human health and environmental risk. 31/12/2024 Health and Environment -
      EVA00147 Phenolic benzotriazoles Evaluation Selection Analysis indicated a potential human health risk. 31/12/2024 Health -
      EVA00150 Salicylic acid and its salts Evaluation Selection Analysis indicated a potential human health and environmental risk. 30/06/2024 Health and Environment -
      EVA00151 Tellurium and its inorganic compounds Evaluation Selection Analysis indicated a potential human health risk. 31/12/2024 Health -

       

      Recently completed evaluations

      ID Subject Reason for evaluation Timeframe Focus Status Reason
      EVA00022 Octanamide, N-Hydroxy- To evaluate information submitted by industry to meet their obligation in the terms of the Inventory listing. 31/12/2022 Health Completed
      EVA00040 Musk tibetene and a structural analogue Evaluation Selection Analysis indicated a potential environmental risk. 31/12/2022 Environment Completed
      EVA00041 1,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro- (Dechlorane Plus) Evaluation Selection Analysis indicated a potential human health and environmental risk. 30/06/2023 Health and Environment Completed
      EVA00055 Benzene, 1,2,3,4,5-pentachloro- (PeCB) Evaluation is needed to provide information on human health and environmental risks. 31/12/2022 Health and Environment Completed
      EVA00056 Benzene, hexachloro- (HCB) Evaluation is needed to provide information on human health and environmental risks. 31/12/2022 Health and Environment Completed
      EVA00060 Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester (carbendazim) An evaluation or assessment recommended further evaluation of specific issues related to the chemical(s). 31/12/2022 Health and Environment Completed
      EVA00090 1-bromo-3-chloropropane and 1,3-dibromopropane Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00091 1-methoxy-4-(2-propenyl)benzene (estragole) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00092 2-Propenamide, 2-methyl- (methacrylamide) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00093 Chemicals not considered for in depth evaluation – Not commercially active in Australia Evaluation is needed to provide information on human health and environmental risks. 30/06/2023 Health and Environment Completed
      EVA00094 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 30/06/2023 Environment Completed
      EVA00095 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 30/06/2023 Health Completed
      EVA00096 Benzaldehyde Evaluation is needed to provide information on human health risks. 30/06/2023 Health Completed
      EVA00097 Aniline and its salts Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00098 Benzene, 1-chloro-4-(trifluoromethyl)- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00099 Peroxide, bis(1-methyl-1-phenylethyl) (dicumyl peroxide) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00100 Use of aluminium in antiperspirants Evaluation is needed to provide information on human health risks. 30/06/2023 Health Completed
      EVA00101 Polymers incorporating glycidyl methacrylate Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00102 Water soluble arsenic compounds Evaluation is needed to provide information on environmental risks. 30/06/2023 Environment Completed
      EVA00103 Tocopherols and their salts and esters Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00104 Cresyl phosphates and xylyl phosphates Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00106 Hydroquinone and p-benzoquinone Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00107 Cadmium sulfide pigments Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00108 Triphenyl phosphate and diphenyl phosphate Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00109 Phenylenediamines Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00110 Glyoxylic acid Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00111 Cyclohexanamine, 4,4'-methylenebis[2-methyl- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00112 Carbamic acid, butyl-, 3-iodo-2-propynyl ester (IPBC) Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00113 Propyl and butyl phenols Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00114 Long chain (C?10) alkyl benzene sulfonates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00115 Polymers with pendant acrylates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00116 Lauryl (dodecyl) sulfates Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment Completed
      EVA00117 Alkyl diphenyl oxide sulfonates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health Completed
      EVA00119 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 31/12/2023 Environment Completed
      EVA00120 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 31/12/2023 Health Completed
      Last updated
      Was this page helpful?
      For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

      Keep informed with updates